Skip to main
DD

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 46%
Hold 23%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours has demonstrated strong growth in its Healthcare and Water segments, with sales increasing in the high-single digits, driven by demand in medical packaging and biopharma solutions. The company’s focus on innovation, evidenced by a shift towards new products as indicated by a vitality index target of 45%, is expected to enhance both pricing and product mix in the coming years. Additionally, the Electronics & Industrial segment is poised for growth propelled by technological advancements such as 5G and IoT expansion, which further supports a positive long-term outlook for the company's valuation.

Bears say

DuPont de Nemours faces significant challenges due to delays in synergy realization following the merger and ongoing weakness in its key markets, particularly electronics and construction. These sectors are critical for the company, and their current performance raises concerns about DuPont’s ability to sustain profitability, especially as recovery in China remains sluggish. As healthcare and water sectors are projected to drive the majority of profits, the dependence on the performance of struggling segments presents a considerable risk to overall financial stability.

DD has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 46% recommend Buy, 23% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 13 analysts, DD has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.